Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Pancreatic Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00789633
What this trial is testing

Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
AB Science 353
Testing effectiveness (Phase 2)Looking for participantsNCT06244771
What this trial is testing

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Who this might be right for
Advanced Solid Tumors With KRAS G12C MutationsSolid Tumor, AdultUnresectable Solid Tumor+5 more
Frontier Medicines Corporation 403
Testing effectiveness (Phase 2)UnknownNCT02461836
What this trial is testing

Study of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1)

Who this might be right for
Pancreatic Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 513
Large-scale testing (Phase 3)Study completedNCT02395016
What this trial is testing

Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Biotech Pharmaceutical Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT00260364
What this trial is testing

Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Royal Marsden NHS Foundation Trust 44
Large-scale testing (Phase 3)Looking for participantsNCT03257033
What this trial is testing

Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

Who this might be right for
Locally Advanced Pancreatic Cancer
RenovoRx 190
Early research (Phase 1)Study completedNCT00544193
What this trial is testing

Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
City of Hope Medical Center 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07683221
What this trial is testing

SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Shandong Cancer Hospital and Institute 47
Early research (Phase 1)Study completedNCT04925284
What this trial is testing

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

Who this might be right for
Non Small Cell Lung CancerCervical CancerSCCHN+8 more
Exelixis 269
Early research (Phase 1)Study completedNCT01294358
What this trial is testing

Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial

Who this might be right for
Histologically or Cytologically Confirmed Pancreatic CaUnresectable or Borderline Resectable Pancreatic Ca
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Study completedNCT02565641
What this trial is testing

Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Hoffmann-La Roche 63
Testing effectiveness (Phase 2)Study completedNCT00338039
What this trial is testing

Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 69
Testing effectiveness (Phase 2)Study completedNCT00998322
What this trial is testing

REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Oncolytics Biotech 34
Testing effectiveness (Phase 2)Looking for participantsNCT06472388
What this trial is testing

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsProgressionNeuroendocrine Tumor Grade 1+4 more
AC Camargo Cancer Center 100
Testing effectiveness (Phase 2)Study completedNCT01821729
What this trial is testing

Radiation w/FOLFIRINOX-Losartan for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Massachusetts General Hospital 50
Large-scale testing (Phase 3)Study completedNCT01827553
What this trial is testing

Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy

Who this might be right for
Pancreatic Cancer
University of Erlangen-Nürnberg Medical School 830
Not applicableNot Yet RecruitingNCT07115420
What this trial is testing

Improving a Bile Duct Drainage Procedure in Patients With Inoperable Cancer Blocking the Bile Ducts: Comparing Two Types of Endoscopically Placed Internal Stents to Prevent Blockage of a Lumen Apposing Metal Stent

Who this might be right for
Malignant Biliary ObstructionAdvanced Pancreatic Cancer and CholangiocarcinomaInoperable Malignant Biliary Obstruction+1 more
Waikato Hospital 100
Early research (Phase 1)Study completedNCT02179970
What this trial is testing

To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers

Who this might be right for
Pancreatic Adenocarcinoma MetastaticOvarian Serous AdenocarcinomaColorectal Cancer Metastatic
CCTU- Cancer Theme 26
Testing effectiveness (Phase 2)Looking for participantsNCT07575191
What this trial is testing

Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Smartwise Sweden AB 9
Testing effectiveness (Phase 2)Study completedNCT00114179
What this trial is testing

Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the PancreasStage II Pancreatic CancerStage III Pancreatic Cancer
National Cancer Institute (NCI) 82
Next Page